Company: SUPN
Filing Date: 2025-06-16
Form Type: 8-K
Source: 0001104659-25-059687
Chunk: 8

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-06-16
Form: 8-K
Item: Item 9.01
Chunk 8
---
Item 9.01      Financial Statements and Exhibits.  

  (d)      Exhibits  

Exhibit 2.1* - Agreement and Plan of Merger, dated as of June 13, 2025, by and among Supernus Pharmaceuticals, Inc., Sage Therapeutics, Inc. and Saphire Inc.

Exhibit 99.1 - Joint Press Release of Supernus Pharmaceuticals, Inc. and Sage Therapeutics, Inc., dated June 16, 2025.

Exhibit 99.2 - Investor Presentation dated June 16, 2025.

Exhibit 104 - The cover page from
this Current Report on Form 8-K, formatted in Inline XBRL.

* Scheduled omitted pursuant to Item 601 of Regulation S-K.
The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request.

SIGNATURES